HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Engineering antibiotic production and overcoming bacterial resistance

Abstract : Progress in DNA technology, analytical methods and computational tools is leading to new developments in synthetic biology and metabolic engineering, enabling new ways to produce molecules of industrial and therapeutic interest. Here, we review recent progress in both antibiotic production and strategies to counteract bacterial resistance to antibiotics. Advances in sequencing and cloning are increasingly enabling the characterization of antibiotic biosynthesis pathways, and new systematic methods for de novo biosynthetic pathway prediction are allowing the exploration of the metabolic chemical space beyond metabolic engineering. Moreover, we survey the computer-assisted design of modular assembly lines in polyketide synthases and non-ribosomal peptide synthases for the development of tailor-made antibiotics. Nowadays, production of novel antibiotic can be tranferred into any chosen chassis by optimizing a host factory through specific strain modifications. These advances in metabolic engineering and synthetic biology are leading to novel strategies for engineering antimicrobial agents with desired specificities.
Document type :
Journal articles
Complete list of metadata

Contributor : Migration Prodinra Connect in order to contact the contributor
Submitted on : Friday, May 29, 2020 - 7:19:09 AM
Last modification on : Wednesday, August 19, 2020 - 1:28:02 PM

Links full text




Anne-Gaëlle Planson, Pablo Carbonell, Ioana Grigoras, Jean-Loup Faulon. Engineering antibiotic production and overcoming bacterial resistance. Biotechnology Journal, Wiley-VCH Verlag, 2011, 6 (7), pp.812-825. ⟨10.1002/biot.201100085⟩. ⟨hal-02647510⟩



Record views